Key facts
- It has raised $4.1M; the latest was Accelerator/Incubator in Nov 2025.
- Notable investors include Techstars, Panache Ventures, Front Row Ventures, Redbud VC, Ripple Ventures — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Asepha
- ·The full record, as it builds
Funding rounds
No funding rounds for Asepha are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Asepha
Developer of an artificial intelligence-based automation platform designed to improve the digital health experience. The company's platform provides a contextual search for drug monographs, treatment guidelines, prescription filtering, diagnostic support, titration schedules, dosing information, and more, enabling pharmacies and healthcare professionals to maximize efficiency, increase productivity, and drive revenue growth.
- Sector
- Healthcare
- HQ
- Toronto, Canada
- Founded
- 2023
- Employees
- 8
- Website
- asepha.ai/
- Ownership
- Privately Held (backing)
Asepha doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Asepha shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Asepha in its N-PORT filings yet. We sweep new filings monthly.